AVADEL PHARMACEUTICALS PLC: cash_and_equivalents
| Value | {"amount": 71722000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2020-12-31) |
| Status | current |
| Entity | AVADEL PHARMACEUTICALS PLC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:49:51.931679+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/a2acbc11-5dda-44f8-8f2f-ca92bfb3c349
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001012477-21-000004 · Open the official SEC filing →Retrieved: 2026-08-19T09:49:51.931679+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001012477/cash-and-equivalents/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/a2acbc11-5dda-44f8-8f2f-ca92bfb3c349
History
- no predecessors — first report